| Summary of Other Issuances and Share Capital Transactions |
During the three months ended June 30, 2026, the Company had the following other issuances and share capital transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common shares |
|
|
Share capital |
|
|
Share and warrant reserve |
|
Other issuances and share issue costs |
|
|
- |
|
|
$ |
(571 |
) |
|
$ |
- |
|
Total |
|
|
- |
|
|
$ |
(571 |
) |
|
$ |
- |
|
During the three months ended June 30, 2025, the Company had the following other issuances and share capital transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common shares |
|
|
Share capital |
|
|
Share based reserve |
|
Other issuances and share issue costs |
|
|
- |
|
|
$ |
(1,585 |
) |
|
$ |
- |
|
Total |
|
|
- |
|
|
$ |
(1,585 |
) |
|
$ |
- |
|
|
| Summary of Warrants |
The following is a summary of the Company’s liability classified warrant activity during the three months ended June 30, 2026 and 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of whole warrants |
|
|
Weighted average exercise price |
|
|
Weighted average remaining life (years) |
|
Balance outstanding at March 31, 2026 |
|
|
30,838,728 |
|
|
$ |
4.49 |
|
|
|
4.11 |
|
Issuance of warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance outstanding at June 30, 2026 |
|
|
30,838,728 |
|
|
$ |
4.58 |
|
|
|
3.87 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of whole warrants |
|
|
Weighted average exercise price |
|
|
Weighted average remaining life (years) |
|
Balance outstanding at March 31, 2025 |
|
|
12,133,150 |
|
|
$ |
8.90 |
|
|
|
4.09 |
|
Issuance of warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance outstanding at June 30, 2025 |
|
|
12,133,150 |
|
|
$ |
8.41 |
|
|
|
3.84 |
|
The following is a summary of the Company’s liability classified warrant balances during the three months ended June 30, 2026 and 2025:
|
|
|
|
|
|
|
Warrant derivative liability |
|
Balance outstanding at March 31, 2026 |
|
$ |
27,522 |
|
Fair value change |
|
|
(659 |
) |
Balance outstanding at June 30, 2026 |
|
$ |
26,863 |
|
|
|
|
|
|
|
|
Warrant derivative liability |
|
Balance outstanding at March 31, 2025 |
|
$ |
8,647 |
|
Fair value change |
|
|
3,334 |
|
Balance outstanding at June 30, 2025 |
|
$ |
11,981 |
|
(iv) Equity classified warrantsThe following is a summary of the Company’s equity classified warrant activity during the three months ended June 30, 2026 and 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of whole warrants |
|
|
Weighted average exercise price |
|
|
Weighted average remaining life (years) |
|
|
Warrant reserve |
|
Balance outstanding at March 31, 2026 |
|
|
23,528,830 |
|
|
$ |
4.08 |
|
|
|
3.46 |
|
|
$ |
2,612,631 |
|
Issuance of warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance outstanding at June 30, 2026 |
|
|
23,528,830 |
|
|
$ |
4.08 |
|
|
|
3.21 |
|
|
$ |
2,612,631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of whole warrants |
|
|
Weighted average exercise price |
|
|
Weighted average remaining life (years) |
|
|
Warrant reserve |
|
Balance outstanding at March 31, 2025 |
|
|
3,350,430 |
|
|
$ |
16.18 |
|
|
|
4.12 |
|
|
$ |
2,590,485 |
|
Issuance of warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance outstanding at June 30, 2025 |
|
|
3,350,430 |
|
|
$ |
16.18 |
|
|
|
3.87 |
|
|
$ |
2,590,485 |
|
|